Dr. Konstantinos Farsalinos Sends the FDA Letter about the AHA HnB Study

Dr. Konstantinos Farsalinos Sends the FDA Letter about the AHA HnB Study

December 06, 2017


In following up with a blog he wrote last week about a study claiming that HnB devices have similar adverse cardiovascular effects as tobacco cigarettes, renowned public health expert Dr. Konstantinos Farsalinos submitted a public comment to the FDA about the matter.

Research conducted by the AHA exposed mice to aerosol emitted by PMI’s Heat-not-Burn (HnB) device iQOS, and claimed that this aerosol had the same negative effects on Flow-Mediated Dilatation (FMD), as cigarette smoke. FMD is a noninvasive method to measure one’s level of endothelial function or dysfunction. “Using heat-not-burn products may not avoid the adverse cardiovascular effects of smoking cigarettes”, concluded the study Abstract.

Last week on his blog E-Cigarette Research, renowned public health Dr. Farsalinos who is a Research Fellow at Onassis Cardiac Surgery Center in Athens, discussed the study in depth. He explained that it is creating unnecessary alarm as “FMD (and other measures of vascular function), have no prognostic value when measured after an acute exposure”, whilst adding that some critical information has been left out of this abstract.

Click Here to Read More at Vaping Post

Sorry, only of the is available to order.

Back to top